What if making your product harder to access was the secret to increasing demand?

That’s the counterintuitive strategy sisters Olivia and Chloe Ferro bet on to catapult their startup SheMed to over 20,000 sign-ups in just a few months.

As the UK’s first female-focused GLP-1 program, SheMed entered a crowded weight-loss market—but instead of competing on convenience, they bet on credibility. By requiring mandatory blood tests before prescribing medication, they not only differentiated themselves but uncovered a staggering insight: 99% of applicants had undiagnosed health conditions.

The payoff? A 3X surge in inbound leads, a 120% increase in patient sign-ups, and high-trust partnerships with major clinics—all fueled by a safety-first approach that turned medical rigor into a viral growth lever.

If you’ve ever worried that implementing stricter client or customer qualifications might slow your sales, this case study is an excellent reminder that trust is your most powerful conversion strategy.

Thank you to our sponsor!

Connect with Chloe + Olivia:

Iconic business leaders all have their own unique genius. Take this quick 10 question quiz to uncover your specific CEO style advantage: ⁠https://cubicletoceo.co/quiz⁠

If you enjoyed today's episode, please:

Learn more about your ad choices. Visit megaphone.fm/adchoices